Research / FICO / Fundamental state Inspectable configuration
State dimensions Filing 0000814547-21-000019 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
56.97% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.57% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
32.19% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
1.70% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
38.40% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.01% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 43 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 6/6 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 6/6 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 238.52%
Current 56.97%
Delta -181.55% Capex Intensity Increased
Previous 0.46%
Current 0.57%
Delta 0.11% Cash Generation Increased
Previous 29.74%
Current 32.19%
Delta 2.45% Growth Decreased
Previous 7.79%
Current 1.70%
Delta -6.10% Profitability Decreased
Previous 57.48%
Current 38.40%
Delta -19.08% R And D Intensity Decreased
Previous 13.55%
Current 13.01%
Delta -0.54% Sbc Intensity Decreased
Previous 9.10%
Current 8.54%
Delta -0.55% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.